Studies emphasize that alternative splicing of osteopontin is not known to occur in mice, and there is no report regarding the investigation of OPN5 in any tumor types or cancer cells in the mouse to the extent of our knowledge [18]. This evidence concerns the gene OPN5 and cancer.